Designation of P2P Methyl Glycidic Acid as a List I Chemical

Document 2026-06523 is a Final Rule published by the Department of Justice in the Federal Register on April 3, 2026, with an effective date of May 4, 2026. The Drug Enforcement Administration is finalizing the control of 2-methyl-3-phenyloxirane-2-carboxylic acid (also known as P2P methyl glycidic acid and BMK glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers and its esters, and any combination thereof, whenever the existence of such is possible, as a list I chemical under the Controlled Substances Act (CSA). P2P methyl glycidic acid is used in the illicit manufacture of the controlled substances phenylacetone (also known as phenyl-2-propanone or P2P), methamphetamine, and amphetamine, and it is important to the manufacture of these substances. This final rule subjects handlers of P2P methyl glycidic acid to the chemical regulatory provisions of the CSA and its implementing regulations. View the original at https://www.federalregister.gov/documents/2026/04/03/2026-06523/designation-of-p2p-methyl-glycidic-acid-as-a-list-i-chemical.

No. Document 2026-06523 is not classified as economically significant under Executive Order 12866. Economically significant rules require OIRA review and are estimated to have impacts of $100 million or more per year.